Mycotic vulvovaginitis: a broad overview.

Abstract

The incidence of mycotic vulvovaginitis is rising dramatically in the United States mainly because of an increase in infections caused by Candida species. Accurate diagnosis depends on culture techniques that will yield correct identification of fungal pathogen(s). Recurrences are common and require culture specimens from sexual partners and appropriate antifungal therapy. The imidazoles and more recently the broader spectrum triazoles are used for vaginal therapy.